Home Newsfeeds VolitionRx Reports FY22 Cash $10.9M

VolitionRx Reports FY22 Cash $10.9M

Cash and cash equivalents as of December 31, 2022 totaled approximately $10.9 million.

byBenzinga Newsdesk

March 15, 2023

1 minute read

Cash and cash equivalents as of December 31, 2022 totaled approximately $10.9 million.

As Tensions Escalate With US Regulators, Coinbase Looks To Strengthen Ties With UAE

By Murtuza Merchant

May 8, 11:37 AM

Coinbase (NASDAQ: COIN) is engaging with regulators in the United Arab Emirates (UAE), namely the Abu Dhabi Global Market (ADGM), to expand the licensing and availability of i

COIN

News
Tech

OpenAI Makes Available ChatGPT For Integration: Shopify, Snap, Instacart And Others Jump On The Chance

By Ananya Gairola

March 2, 5:02 AM

OpenAI’s chatGPT is the latest language model to take the business world by storm â€” Instacart Inc., Shopify…

MSFT

News

Innate Pharma Announced That Sanofi Has Made Decision to Progress IPH6401/SAR’514 Into Investigational New Drug-enabling Studies, Triggering €3M Milestone Payment

By Charles Gross

July 21, 5:02 AM

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that Sanofi has made the decision to progress IPH6401/SAR'514 into investigational new drug (IND)-enabling studies, triggering a €3 million milestone payment.

IPHA